Q1 EPS Estimates for Aspen Aerogels Raised by Roth Capital

Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) - Equities researchers at Roth Capital raised their Q1 2025 earnings per share (EPS) estimates for Aspen Aerogels in a research note issued to investors on Friday, November 8th. Roth Capital analyst C. Moore now forecasts that the construction company will earn $0.04 per share for the quarter, up from their previous forecast of $0.02. The consensus estimate for Aspen Aerogels' current full-year earnings is $0.10 per share. Roth Capital also issued estimates for Aspen Aerogels' Q3 2025 earnings at $0.23 EPS.

A number of other analysts also recently weighed in on ASPN. Piper Sandler decreased their price target on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. Barclays started coverage on shares of Aspen Aerogels in a research report on Tuesday, August 6th. They set an "overweight" rating and a $27.00 target price on the stock. Roth Mkm dropped their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a research note on Friday. TD Cowen lifted their target price on Aspen Aerogels from $36.00 to $41.00 and gave the company a "buy" rating in a report on Tuesday, August 20th. Finally, StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $28.90.

Aspen Aerogels Stock Performance

Shares of ASPN traded up $0.93 during mid-day trading on Monday, hitting $17.42. 1,067,416 shares of the company's stock were exchanged, compared to its average volume of 1,568,043. Aspen Aerogels has a fifty-two week low of $8.79 and a fifty-two week high of $33.15. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The business's 50 day moving average is $23.10 and its two-hundred day moving average is $24.73. The firm has a market capitalization of $1.34 billion, a P/E ratio of 1,729.73 and a beta of 2.21.

Insider Activity

In related news, CEO Donald R. Young sold 63,355 shares of the business's stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares of the company's stock, valued at $626,610.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.30% of the company's stock.

Institutional Investors Weigh In On Aspen Aerogels

A number of institutional investors and hedge funds have recently made changes to their positions in ASPN. Point72 Hong Kong Ltd acquired a new stake in Aspen Aerogels during the 2nd quarter worth approximately $84,000. nVerses Capital LLC acquired a new position in shares of Aspen Aerogels in the second quarter valued at about $95,000. Quent Capital LLC bought a new position in Aspen Aerogels during the third quarter worth about $118,000. Point72 DIFC Ltd bought a new position in shares of Aspen Aerogels during the second quarter worth approximately $121,000. Finally, Public Employees Retirement Association of Colorado acquired a new stake in shares of Aspen Aerogels in the second quarter valued at approximately $145,000. Institutional investors own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.